Skip to main content

Table 1 Patient demographics, disease, and treatment characteristics

From: Evaluation of pediatric rheumatology telehealth satisfaction during the COVID-19 pandemic

Variable N = 248a
Patient Age
  ≤ 5 years 35 (14.1%)
 6–12 years 68 (27.4%)
 13–17 years 118 (47.6%)
  ≥ 18 years 27 (10.9%)
Race
 Caucasian 188 (75.8%)
 African American 16 (6.5%)
 Asian 17 (6.9%)
 Other 27 (10.9%)
Condition
 Juvenile idiopathic arthritis 83 (33.5%)
 Systemic lupus erythematosus 16 (6.5%)
 Inflammatory diseaseb 40 (16.1%)
 Amplified musculoskeletal pain 36 (14.5%)
 Other/Unknown 73 (29.4%)
Rheumatologic diagnosis in the past 6 months 59 (23.8%)
Prescribed rheumatologic medication(s) 148 (59.7%)
Glucocorticoid therapy for rheumatologic condition 36 (14.5%)
Rheumatology new patient visit (n = 212) 85 (40.1%)
  1. aUnless otherwise indicated
  2. bDiagnoses included in the “inflammatory disease” category include Sjogren syndrome, vasculitis, juvenile dermatomyositis, chronic nonbacterial osteomyelitis, idiopathic uveitis, localized scleroderma, systemic sclerosis, Behcet syndrome, sarcoidosis, and periodic fever syndrome or auto-inflammatory disorder